{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_mipomersen",
          "name": "Mipomersen"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_evolocumab",
          "name": "Evolocumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_alirocumab",
          "name": "Alirocumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_bezafibrate",
          "name": "Bezafibrate"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_fibrates",
          "type": "Drug",
          "label": "Fibrates",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_omega_3",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_statins",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_lomitapide",
          "type": "Drug",
          "label": "Lomitapide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_mipomersen",
          "type": "Drug",
          "label": "Mipomersen",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_evolocumab",
          "type": "Drug",
          "label": "Evolocumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_alirocumab",
          "type": "Drug",
          "label": "Alirocumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_asprin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_bezafibrate",
          "type": "Drug",
          "label": "Bezafibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk1",
          "type": "Pathway",
          "label": "Liver toxicity pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Liver dysfunction",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk2",
          "type": "Pathway",
          "label": "Myopathy risk pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv2",
          "type": "Phenotype",
          "label": "Myopathy",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_fibrates",
          "target": "n_risk1",
          "relation": "potentially_causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知对肝脏函数有影响"
        },
        {
          "source": "n_niacin",
          "target": "n_risk1",
          "relation": "potentially_causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致肝毒性"
        },
        {
          "source": "n_statins",
          "target": "n_risk2",
          "relation": "potentially_causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与肌病风险相关"
        },
        {
          "source": "n_lomitapide",
          "target": "n_risk1",
          "relation": "potentially_causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "引起肝脏副作用的报告"
        },
        {
          "source": "n_mipomersen",
          "target": "n_risk1",
          "relation": "potentially_causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知引起肝毒性"
        },
        {
          "source": "n_evolocumab",
          "target": "n_adv2",
          "relation": "potentially_causes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "对肌肉效应的潜在影响"
        },
        {
          "source": "n_alirocumab",
          "target": "n_adv2",
          "relation": "potentially_causes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "与肌病风险存在联系"
        },
        {
          "source": "n_fibrates",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "已知剂量相关性"
        },
        {
          "source": "n_niacin",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与肝功能影响相关"
        },
        {
          "source": "n_statins",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "明确的肌病风险"
        },
        {
          "source": "n_lomitapide",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "严重的肝损伤风险"
        },
        {
          "source": "n_mipomersen",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "长期使用的肝毒性风险"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "drug_safety",
          "pro_nodes": [
            "n_fibrates",
            "n_niacin"
          ],
          "con_nodes": [
            "n_adv1",
            "n_adv2"
          ],
          "note": "不同的药物之间安全性风险的潜在差异"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "某些药物对高甘油三酯血症的效果可能在短期内显著，但长期使用的安全性尚无背景支持",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "药物作用机制可能不一致，存在不良反应的可能性",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "所有药物在减轻高甘油三酯水平上均可实现相似安全性。",
      "长时间使用后对肝脏和肌肉的损害评价不足。"
    ],
    "falsification_tests": [
      "是否存在显示长期安全性的高质量临床试验数据？",
      "是否研究了不同药物对高甘油三酯血症的效果及其长期风险的比较？"
    ],
    "next_focus_for_pi": [
      "基于具体药物的风险和效益进行进一步的分析。",
      "要求 Proponent 提供对比研究的可靠数据，以验证假设。"
    ]
  }
}